Role of Renal Parenchyma Attenuation and Perirenal Fat Stranding in Chest CT of Hospitalized Patients with COVID-19.

COVID SARS-CoV-2 acute kidney injury computed tomography mortality risk perirenal fat stranding renal parenchyma attenuation

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
25 Jan 2023
Historique:
received: 22 12 2022
revised: 19 01 2023
accepted: 20 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 12 2 2023
Statut: epublish

Résumé

Chest CT on coronavirus disease (COVID-19) has been extensively investigated. Acute kidney injury (AKI) has been widely described among COVID patients, but the role of kidney imaging has been poorly explored. The aim of this study is to clarify the role of opportunistic kidney assessment on non-enhanced chest CT. We collected data on patients with COVID-19 consecutively admitted to our institution who underwent chest CT (including the upper parts of kidneys as per protocol). Three ROIs of 0.5-0.7 cm 86 patients with COVID-19 and unenhanced chest CT were analyzed. The cohort was split into CT RPA quartiles. Patients with a CT RPA <24 HU were more likely to develop AKI when compared with other patients (χ Detection of low RPA values and of PFS in COVID-19 patients independently predicts, respectively, the occurrence of AKI and an increased risk for mortality. Therefore, opportunistic kidney assessment during chest CT could help physicians in defining diagnostic and therapeutic strategies.

Sections du résumé

BACKGROUND BACKGROUND
Chest CT on coronavirus disease (COVID-19) has been extensively investigated. Acute kidney injury (AKI) has been widely described among COVID patients, but the role of kidney imaging has been poorly explored. The aim of this study is to clarify the role of opportunistic kidney assessment on non-enhanced chest CT.
METHODS METHODS
We collected data on patients with COVID-19 consecutively admitted to our institution who underwent chest CT (including the upper parts of kidneys as per protocol). Three ROIs of 0.5-0.7 cm
RESULTS RESULTS
86 patients with COVID-19 and unenhanced chest CT were analyzed. The cohort was split into CT RPA quartiles. Patients with a CT RPA <24 HU were more likely to develop AKI when compared with other patients (χ
CONCLUSIONS CONCLUSIONS
Detection of low RPA values and of PFS in COVID-19 patients independently predicts, respectively, the occurrence of AKI and an increased risk for mortality. Therefore, opportunistic kidney assessment during chest CT could help physicians in defining diagnostic and therapeutic strategies.

Identifiants

pubmed: 36769577
pii: jcm12030929
doi: 10.3390/jcm12030929
pmc: PMC9918001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Adv Exp Med Biol. 2021;1321:309-324
pubmed: 33656736
J Am Soc Nephrol. 2020 Sep;31(9):2158-2167
pubmed: 32727719
Eur J Radiol. 2020 Oct;131:109240
pubmed: 32920219
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
Investig Clin Urol. 2021 Jan;62(1):23-31
pubmed: 33314805
Intensive Care Med. 2020 Jun;46(6):1114-1116
pubmed: 32236644
Kidney Int. 2020 Jul;98(1):219-227
pubmed: 32327202
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Eur Radiol. 2021 Feb;31(2):1090-1099
pubmed: 32860146
Radiol Med. 2020 May;125(5):500-504
pubmed: 32367319
Am J Physiol Renal Physiol. 2020 Jun 1;318(6):F1454-F1462
pubmed: 32412303
J Nephrol. 2021 Feb;34(1):173-183
pubmed: 33025516
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
Abdom Radiol (NY). 2021 Apr;46(4):1651-1658
pubmed: 33098478
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280
pubmed: 32107577
Invest Radiol. 2020 Jun;55(6):327-331
pubmed: 32118615
J Am Soc Nephrol. 2020 Jun;31(6):1157-1165
pubmed: 32345702
J Am Soc Nephrol. 2020 Sep;31(9):1959-1968
pubmed: 32680910
BMC Nephrol. 2021 Aug 31;22(1):297
pubmed: 34465289
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
Sci Rep. 2020 Dec 28;10(1):22402
pubmed: 33372194
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
Kidney Int. 2020 May;97(5):824-828
pubmed: 32204907
Nat Rev Nephrol. 2020 Jun;16(6):308-310
pubmed: 32273593
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Clin Imaging. 2020 Oct;66:35-41
pubmed: 32425338
Front Cell Dev Biol. 2022 Jan 18;9:784505
pubmed: 35118071
Rev Med Virol. 2021 May;31(3):e2176
pubmed: 33022818

Auteurs

Elisa Russo (E)

Nephrology Unit, Ospedale San Luca, 55100 Lucca, Italy.

Alberto Stefano Tagliafico (AS)

Department of Health Sciences (DISSAL), University of Genova, 16126 Genova, Italy.
Radiologic Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Lorenzo Derchi (L)

Radiologic Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Bianca Bignotti (B)

Department of Health Sciences (DISSAL), University of Genova, 16126 Genova, Italy.
Department of Experimental Medicine (DIMES), University of Genova, 16126 Genova, Italy.

Simona Tosto (S)

Department of Health Sciences (DISSAL), University of Genova, 16126 Genova, Italy.

Carlo Martinoli (C)

Radiologic Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Alessio Signori (A)

Department of Experimental Medicine (DIMES), University of Genova, 16126 Genova, Italy.

Francesca Brigati (F)

Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Francesca Viazzi (F)

Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Classifications MeSH